World Health Organization

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

International Agency for Research on Cancer

Oral contraceptives for family planning worldwide have revolutionized the reproductive lives of millions of women since their introduction in the 1960s. Later on, a variety of side-effects including cardiovascular diseases was recognized. In response to these concerns, new generations of combined oral contraceptives were developed that featured lower dose of estrogen and newer, more potent progestogens. The effectiveness and ease of use of combined hormonal contraceptives suggest that they will continue to be used to a significant extent in the future. This ninety-first volume of IARC Monograp.

Books like Combined Estrogen-progestogen Contraceptives and Combined Estrogen-progestogen Menopausal Therapy

Your next favorite book is out there